Myriam Bénamor

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 351 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Aaron Miller, Jerry S. Wolinsky, Ludwig Kappos et al. · The Lancet Neurology · 2014 · 298 citations

Life Sciences, Neurology, Pharmacotherapy +7

Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non–Sentinel Node Involvement After Positive Sentinel Node Biopsy

S. Alran, Yann De Rycke, Virginie Fourchotte et al. · Annals of Surgical Oncology · 2007 · 147 citations

Medicine, Oncology, Breast Oncology +13

18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging

G Moulin-Romsee, Elif Hindié, X. Cuenca et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 143 citations

Medicine, Oncology, Radiology +15

Long-term safety and efficacy of teriflunomide

Paul O’Connor, Mark S. Freedman, Aaron Miller et al. · Neurology · 2016 · 126 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15